JMJD6 promotes melanoma carcinogenesis through regulation of the alternative splicing of PAK1, a key MAPK signaling component
2017 · Molecular Cancer · 94 citations
https://doi.org/10.1186/s12943-017-0744-2
L
Lin He
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
103
Papers
2.4K
Citations
22
h-index
34
i10-index
Lin He is an academic researcher from Beijing Institute of Technology. The author has contributed to research in topics: CAR-T cell therapy research & Multiple Myeloma Research and Treatments & Chronic Lymphocytic Leukemia Research. The author has an h-index of 22, co-authored 88 publications.
ORCID: 0000-0001-7429-8012Papers by this author
worksThe existence of a nonclassical TCA cycle in the nucleus that wires the metabolic-epigenetic circuitry
2021 · Signal Transduction and Targeted Therapy · 89 citations
https://doi.org/10.1038/s41392-021-00774-2
ZNF516 suppresses EGFR by targeting the CtBP/LSD1/CoREST complex to chromatin
2017 · Nature Communications · 74 citations
https://doi.org/10.1038/s41467-017-00702-5
TRPS1 drives heterochromatic origin refiring and cancer genome evolution
2021 · Cell Reports · 37 citations
https://doi.org/10.1016/j.celrep.2021.108814
NSD family proteins: Rising stars as therapeutic targets
2024 · Cell Insight · 16 citations
https://doi.org/10.1016/j.cellin.2024.100151
Down-regulation of argininosuccinate lyase induces hepatoma cell apoptosis through activating Bax signaling pathway
2018 · Genes & Diseases · 12 citations
https://doi.org/10.1016/j.gendis.2018.11.003
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat